Certified by Founder Lodge
Canaan
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $21,000,000
60 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With a diversified fund and over 200 exits to date, Canaan has invested in some of the world'
| Company | Date | Round | Raised |
|---|---|---|---|
 Hermeus |
March, 10 ,2022 | Unknown | $100,000,000 |
 Alkymi |
October, 06 ,2022 | Series A | $21,000,000 |
 Earnipay |
February, 17 ,2022 | Seed | $4,000,000 |
 Pin |
August, 25 ,2022 | Seed | $5,600,000 |
 Instrumental Inc. |
February, 17 ,2022 | Series C | $50,000,000 |
 Komprise |
January, 25 ,2023 | Unknown | $37,000,000 |
 withco |
February, 01 ,2022 | Unknown | $32,000,000 |
 Hank |
June, 28 ,2022 | Seed | $7,000,000 |
 Appsmith |
June, 22 ,2022 | Series B | $41,000,000 |
 Mantra Health |
January, 19 ,2022 | Series A | $22,000,000 |
| Hermeus |
March, 10 ,2022 | Unknown | $100,000,000 |
 Aer Therapeutics, Inc. |
April, 17 ,2023 | Series A | $36,000,000 |
| Earnipay |
February, 17 ,2022 | Seed | $4,000,000 |
 Relievant Medsystems, Inc. |
April, 21 ,2023 | Unknown | $50,000,000 |
| Instrumental Inc. |
February, 17 ,2022 | Series C | $50,000,000 |
 Antiva Biosciences, Inc. |
April, 27 ,2023 | Series E | $53,000,000 |
| withco |
February, 01 ,2022 | Unknown | $32,000,000 |
 OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
| Mantra Health |
January, 19 ,2022 | Series A | $22,000,000 |
 Savvy |
July, 11 ,2023 | Unknown | $30,000,000 |
| Aer Therapeutics, Inc. |
April, 17 ,2023 | Series A | $36,000,000 |
 Atmosfy |
August, 11 ,2023 | Seed | $12,000,000 |
| Relievant Medsystems, Inc. |
April, 21 ,2023 | Unknown | $50,000,000 |
 JOOR |
October, 18 ,2023 | Unknown | $25,000,000 |
| Antiva Biosciences, Inc. |
April, 27 ,2023 | Series E | $53,000,000 |
 Otto (US) |
November, 14 ,2023 | Unknown | $4,500,000 |
| OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
| Savvy |
July, 11 ,2023 | Unknown | $30,000,000 |
 BINARLY🔬 |
March, 27 ,2024 | Seed | $10,500,000 |
| Atmosfy |
August, 11 ,2023 | Seed | $12,000,000 |
 Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
| JOOR |
October, 18 ,2023 | Unknown | $25,000,000 |
 Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
| Otto (US) |
November, 14 ,2023 | Unknown | $4,500,000 |
 Qlaris Bio, Inc. |
April, 30 ,2024 | Series B | $24,000,000 |
| Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
 Nivoda |
May, 14 ,2024 | Series B | $30,000,000 |
| BINARLY🔬 |
March, 27 ,2024 | Seed | $10,500,000 |
 Truveris |
May, 15 ,2024 | Series E | $15,000,000 |
| Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
 Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
| Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
 Nagish |
July, 11 ,2024 | Unknown | $16,000,000 |
| Qlaris Bio, Inc. |
April, 30 ,2024 | Series B | $24,000,000 |
 CatalYm GmbH |
July, 16 ,2024 | Series D | $150,000,000 |
| Nivoda |
May, 14 ,2024 | Series B | $30,000,000 |
 AttoTude |
September, 11 ,2024 | Series A | $29,000,000 |
| Truveris |
May, 15 ,2024 | Series E | $15,000,000 |
 Safire Technology Group, Inc. |
September, 20 ,2024 | Unknown | $8,000,000 |
| Grey Wolf Therapeutics |
May, 23 ,2024 | Series B | $50,000,000 |
 Glooko |
October, 11 ,2024 | Series F | $100,000,000 |
| Nagish |
July, 11 ,2024 | Unknown | $16,000,000 |
 Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
| CatalYm GmbH |
July, 16 ,2024 | Series D | $150,000,000 |
| AttoTude |
September, 11 ,2024 | Series A | $29,000,000 |
| Safire Technology Group, Inc. |
September, 20 ,2024 | Unknown | $8,000,000 |
| Glooko |
October, 11 ,2024 | Series F | $100,000,000 |
| Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
 WiseLayer |
January, 29 ,2025 | Unknown | $7,200,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
